Analyze Diet
Frontiers in veterinary science2016; 3; 80; doi: 10.3389/fvets.2016.00080

A Novel Model for Acute Peripheral Nerve Injury in the Horse and Evaluation of the Effect of Mesenchymal Stromal Cells Applied In Situ on Nerve Regeneration: A Preliminary Study.

Abstract: Transplantation of mesenchymal stromal cells (MSCs) to sites of experimentally created nerve injury in laboratory animals has shown promising results in restoring nerve function. This approach for nerve regeneration has not been reported in horses. In this study, we first evaluated the ability of equine bone marrow-derived MSCs (EBM-MSCs) to trans-differentiate into Schwann-like cells and subsequently tested the MSCs for their potential to regenerate a transected nerve after implantation. The EBM-MSCs from three equine donors were differentiated into SCLs for 7 days, , in the presence of specialized differentiation medium and evaluated for morphological characteristics, by using confocal microscopy, and for protein characteristics, by using selected Schwann cell markers (GFAP and S100b). The EBM-MSCs were then implanted into the fascia surrounding the of one fore limb of three healthy horses after a portion of this nerve was excised. The excised portion of the nerve was examined histologically at the time of transection, and stumps of the nerve were examined histologically at day 45 after transplantation. The EBM-MSCs from all donors demonstrated morphological and protein characteristics of those of Schwann cells 7 days after differentiation. Nerves implanted with EBM-MSCs after nerve transection did not show evidence of nerve regeneration at day 45. Examination of peripheral nerves collected 45 days after injury and stem cell treatment revealed no histological differences between nerves treated with MSCs and those treated with isotonic saline solution (controls). The optimal delivery of MSCs and the model suitable to study the efficacy of MSCs in nerve regeneration should be investigated.
Publication Date: 2016-09-15 PubMed ID: 27695697PubMed Central: PMC5023688DOI: 10.3389/fvets.2016.00080Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article presents a preliminary investigation into the potential of equine bone marrow-derived mesenchymal stromal cells (EBM-MSCs) to aid in the regeneration of damaged nerves in horses. However, this attempt did not indicate any significant nerve regeneration within the evaluated period of 45 days.

The Experiment

  • In this study, the researchers endeavored to assess the capacity of EBM-MSCs to transform into Schwann-like cells (SCLs). These are specialized cells known to help repair damaged nerves in mammals.
  • EBM-MSCs were collected from three horse donors and were then differentiated into SCLs under controlled conditions for a week. The differentiation was conducted using a specialized medium.
  • The evolved cells post-differentiation were scrutinized for their morphological attributes through confocal (laser scanning) microscopy. Additionally, the examination of protein characteristics was conducted applying selected Schwann cell markers, GFAP, and S100b.

Application and Results

  • A part of the nerve extracted from the forelimb of three healthy horses was then replaced with the differentiated EBM-MSCs. The original excised nerve was studied histologically at the point of transection, while the nerve stumps were evaluated similarly on the 45th day after transplantation.
  • The EBM-MSCs transformed into Schwann-like cells exhibiting necessary morphological and protein characteristics.
  • However, the nerves implanted with EBM-MSCs didn’t show any indication of significant regeneration when examined 45 days post-implantation.
  • When comparing the peripheral nerves treated with MSCs and those treated with a control (isotonic saline solution) 45 days after injury, no significant differences were observed in terms of histology.

Conclusions and Future Investigations

  • Overall, while the capacity of EBM-MSCs to differentiate into Schwann-like cells was demonstrated, the anticipated nerve regeneration did not manifest in the experimental timeframe, necessitating further investigation.
  • The researchers concluded that while their novel attempt at nerve regeneration using EBM-MSCs showed promise, it was not fruitful in this experiment. The optimal methods for applying MSCs and suitable models to examine their efficacy in nerve regeneration require further study.

Cite This Article

APA
Cruz Villagrán C, Schumacher J, Donnell R, Dhar MS. (2016). A Novel Model for Acute Peripheral Nerve Injury in the Horse and Evaluation of the Effect of Mesenchymal Stromal Cells Applied In Situ on Nerve Regeneration: A Preliminary Study. Front Vet Sci, 3, 80. https://doi.org/10.3389/fvets.2016.00080

Publication

ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 3
Pages: 80
PII: 80

Researcher Affiliations

Cruz Villagrán, Claudia
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee , Knoxville, TN , USA.
Schumacher, Jim
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee , Knoxville, TN , USA.
Donnell, Robert
  • Department of Biomedical and Diagnostic Sciences, College of Veterinary Medicine, University of Tennessee , Knoxville, TN , USA.
Dhar, Madhu S
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Tennessee , Knoxville, TN , USA.

References

This article includes 32 references
  1. James FM, Engiles JB, Beech J. Meningitis, cranial neuritis, and radiculoneuritis associated with Borrelia burgdorferi infection in a horse.. J Am Vet Med Assoc 2010 Nov 15;237(10):1180-5.
    doi: 10.2460/javma.237.10.1180pubmed: 21073390google scholar: lookup
  2. Wylie CE, Proudman CJ, McGorum BC, Newton JR. A nationwide surveillance scheme for equine grass sickness in Great Britain: results for the period 2000-2009.. Equine Vet J 2011 Sep;43(5):571-9.
  3. Schwarz BC, Sallmutter T, Nell B. Keratoconjunctivitis sicca attributable to parasympathetic facial nerve dysfunction associated with hypothyroidism in a horse.. J Am Vet Med Assoc 2008 Dec 1;233(11):1761-6.
    doi: 10.2460/javma.233.11.1761pubmed: 19046036google scholar: lookup
  4. Morell P, Quarles RH. Myelin formation, structure, and biochemistry. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects Chapter 4. Philadelphia, PA: Lippincott-Raven; (1999).
  5. Lindsay RM. Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: an overview.. Philos Trans R Soc Lond B Biol Sci 1996 Mar 29;351(1338):365-73.
    doi: 10.1098/rstb.1996.0030pubmed: 8730773google scholar: lookup
  6. Cho HH, Jang S, Lee SC, Jeong HS, Park JS, Han JY, Lee KH, Cho YB. Effect of neural-induced mesenchymal stem cells and platelet-rich plasma on facial nerve regeneration in an acute nerve injury model.. Laryngoscope 2010 May;120(5):907-13.
    doi: 10.1002/lary.20860pubmed: 20422684google scholar: lookup
  7. Mahay D, Terenghi G, Shawcross SG. Schwann cell mediated trophic effects by differentiated mesenchymal stem cells.. Exp Cell Res 2008 Aug 15;314(14):2692-701.
    doi: 10.1016/j.yexcr.2008.05.013pubmed: 18586239google scholar: lookup
  8. Dyck PJ, Thomas PK. Peripheral Neuropathy. Pennsylvania, USA: Elsevier Saunders; (2005).
  9. Seddon HJ. A Classification of Nerve Injuries.. Br Med J 1942 Aug 29;2(4260):237-9.
    doi: 10.1136/bmj.2.4270.560-bpmc: PMC2164137pubmed: 20784403google scholar: lookup
  10. Lee SK, Wolfe SW. Peripheral nerve injury and repair.. J Am Acad Orthop Surg 2000 Jul-Aug;8(4):243-52.
  11. Kuffler DP. An assessment of current techniques for inducing axon regeneration and neurological recovery following peripheral nerve trauma.. Prog Neurobiol 2014 May;116:1-12.
  12. Desouches C, Alluin O, Mutaftschiev N, Dousset E, Magalon G, Boucraut J, Feron F, Decherchi P. [Peripheral nerve repair: 30 centuries of scientific research].. Rev Neurol (Paris) 2005 Nov;161(11):1045-59.
    doi: 10.1016/S0035-3787(05)85172-0pubmed: 16288170google scholar: lookup
  13. Seckel BR. Enhancement of peripheral nerve regeneration.. Muscle Nerve 1990 Sep;13(9):785-800.
    doi: 10.1002/mus.880130904pubmed: 2233865google scholar: lookup
  14. Keilhoff G, Stang F, Goihl A, Wolf G, Fansa H. Transdifferentiated mesenchymal stem cells as alternative therapy in supporting nerve regeneration and myelination.. Cell Mol Neurobiol 2006 Oct-Nov;26(7-8):1235-52.
    doi: 10.1007/s10571-006-9029-9pubmed: 16779672google scholar: lookup
  15. Schaakxs D, Kalbermatten DF, Raffoul W, Wiberg M, Kingham PJ. Regenerative cell injection in denervated muscle reduces atrophy and enhances recovery following nerve repair.. Muscle Nerve 2013 May;47(5):691-701.
    doi: 10.1002/mus.23662pubmed: 23504573google scholar: lookup
  16. Dezawa M, Takahashi I, Esaki M, Takano M, Sawada H. Sciatic nerve regeneration in rats induced by transplantation of in vitro differentiated bone-marrow stromal cells.. Eur J Neurosci 2001 Dec;14(11):1771-6.
  17. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.. Blood 2002 May 15;99(10):3838-43.
    doi: 10.1182/blood.V99.10.3838pubmed: 11986244google scholar: lookup
  18. Liotta F, Angeli R, Cosmi L, Filì L, Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V, Santarlasci V, Consoloni L, Angelotti ML, Romagnani P, Parronchi P, Krampera M, Maggi E, Romagnani S, Annunziato F. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.. Stem Cells 2008 Jan;26(1):279-89.
    doi: 10.1634/stemcells.2007-0454pubmed: 17962701google scholar: lookup
  19. Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.. Stem Cell Res 2009 Jul;3(1):63-70.
    doi: 10.1016/j.scr.2009.02.006pubmed: 19411199google scholar: lookup
  20. Spejo AB, Carvalho JL, Goes AM, Oliveira AL. Neuroprotective effects of mesenchymal stem cells on spinal motoneurons following ventral root axotomy: synapse stability and axonal regeneration.. Neuroscience 2013 Oct 10;250:715-32.
  21. Keilhoff G, Goihl A, Langnäse K, Fansa H, Wolf G. Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells.. Eur J Cell Biol 2006 Jan;85(1):11-24.
    doi: 10.1016/j.ejcb.2005.09.021pubmed: 16373171google scholar: lookup
  22. Kingham PJ, Kalbermatten DF, Mahay D, Armstrong SJ, Wiberg M, Terenghi G. Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro.. Exp Neurol 2007 Oct;207(2):267-74.
  23. Cruz Villagrán C, Amelse L, Neilsen N, Dunlap J, Dhar M. Differentiation of equine mesenchymal stromal cells into cells of neural lineage: potential for clinical applications.. Stem Cells Int 2014;2014:891518.
    doi: 10.1155/2014/891518pmc: PMC4260374pubmed: 25506367google scholar: lookup
  24. Arnhold SJ, Goletz I, Klein H, Stumpf G, Beluche LA, Rohde C, Addicks K, Litzke LF. Isolation and characterization of bone marrow-derived equine mesenchymal stem cells.. Am J Vet Res 2007 Oct;68(10):1095-105.
    doi: 10.2460/ajvr.68.10.1095pubmed: 17916017google scholar: lookup
  25. Campbell WW. Evaluation and management of peripheral nerve injury.. Clin Neurophysiol 2008 Sep;119(9):1951-65.
    doi: 10.1016/j.clinph.2008.03.018pubmed: 18482862google scholar: lookup
  26. Forostyak S, Jendelova P, Sykova E. The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.. Biochimie 2013 Dec;95(12):2257-70.
    doi: 10.1016/j.biochi.2013.08.004pubmed: 23994163google scholar: lookup
  27. Widgerow AD, Salibian AA, Lalezari S, Evans GR. Neuromodulatory nerve regeneration: adipose tissue-derived stem cells and neurotrophic mediation in peripheral nerve regeneration.. J Neurosci Res 2013 Dec;91(12):1517-24.
    doi: 10.1002/jnr.23284pmc: PMC7061900pubmed: 24105674google scholar: lookup
  28. Himeno T, Kamiya H, Naruse K, Cheng Z, Ito S, Kondo M, Okawa T, Fujiya A, Kato J, Suzuki H, Kito T, Hamada Y, Oiso Y, Isobe K, Nakamura J. Mesenchymal stem cell-like cells derived from mouse induced pluripotent stem cells ameliorate diabetic polyneuropathy in mice.. Biomed Res Int 2013;2013:259187.
    doi: 10.1155/2013/259187pmc: PMC3844199pubmed: 24319678google scholar: lookup
  29. Nishida H, Nakayama M, Tanaka H, Kitamura M, Hatoya S, Sugiura K, Suzuki Y, Ide C, Inaba T. Evaluation of transplantation of autologous bone marrow stromal cells into the cerebrospinal fluid for treatment of chronic spinal cord injury in dogs.. Am J Vet Res 2011 Aug;72(8):1118-23.
    doi: 10.2460/ajvr.72.8.1118pubmed: 21801071google scholar: lookup
  30. Caddick J, Kingham PJ, Gardiner NJ, Wiberg M, Terenghi G. Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage.. Glia 2006 Dec;54(8):840-9.
    doi: 10.1002/glia.20421pubmed: 16977603google scholar: lookup
  31. Tondreau T, Lagneaux L, Dejeneffe M, Massy M, Mortier C, Delforge A, Bron D. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation.. Differentiation 2004 Sep;72(7):319-26.
  32. Zhu H, Yang A, Du J, Li D, Liu M, Ding F, Gu X, Liu Y. Basic fibroblast growth factor is a key factor that induces bone marrow mesenchymal stem cells towards cells with Schwann cell phenotype.. Neurosci Lett 2014 Jan 24;559:82-7.
    doi: 10.1016/j.neulet.2013.11.044pubmed: 24309293google scholar: lookup

Citations

This article has been cited 3 times.
  1. Ferreira LVO, Kamura BDC, Oliveira JPM, Chimenes ND, Carvalho M, Santos LAD, Dias-Melicio LA, Amorim RL, Amorim RM. In Vitro Transdifferentiation Potential of Equine Mesenchymal Stem Cells into Schwann-Like Cells. Stem Cells Dev 2023 Jul;32(13-14):422-432.
    doi: 10.1089/scd.2022.0274pubmed: 37071193google scholar: lookup
  2. Cequier A, Sanz C, Rodellar C, Barrachina L. The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses. Animals (Basel) 2021 Mar 25;11(4).
    doi: 10.3390/ani11040931pubmed: 33805967google scholar: lookup
  3. Ferreira LVO, Amorim RM. Perspectives on Schwann-like cells derived from bone marrow-mesenchymal stem cells: Advancing peripheral nerve injury therapies. World J Stem Cells 2025 Feb 26;17(2):102702.
    doi: 10.4252/wjsc.v17.i2.102702pubmed: 40061268google scholar: lookup